Skip to main content
Equibles

MARSHALL WACE, LLP

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1318757 LONDON, X0
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$931,722
+$714,646 QoQ
Shares Held
177,471
+204.1% QoQ
Ownership
0.469%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 98 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. LFCR ranks #21 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 4,217,767 $146,229,981
2 ELAN
Elanco Animal Health Inc
 4,432,350 $109,080,132
3 LNTH
Lantheus Holdings, Inc.
 773,978 $85,865,119
4 ALKS
Alkermes plc.
 969,954 $50,825,589
5 NBIX
Neurocrine Biosciences Inc
 270,754 $45,632,878
6 RDY
Dr Reddys Laboratories Ltd
 2,025,356 $29,347,408
7 AMPH
Amphastar Pharmaceuticals, Inc.
 1,066,322 $21,518,377
8 ZTS
Zoetis Inc.
 257,470 $18,501,794

All Filings in LFCR

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $931,722 177,471
2026-03-31 $217,076 58,354
2025-12-31 $904,879 110,621
2025-09-30 $839,592 114,075
2025-06-30 $287,058 35,352
2025-03-31 $477,452 67,820
2024-12-31 $989,608 133,191
2024-09-30 $989,450 200,700
2024-06-30 $1,539,614 300,120
2024-03-31 $850,837 160,233
2023-12-31 $890,697 143,893
2023-09-30 $676,706 89,630
2023-06-30 $1,228,737 127,067
2021-12-31 $1,154 104